(S (NP (NP (NNP Cardiotoxicity)) (VP (VBN related) (PP (TO to) (NP (NN cancer) (NNS therapies))))) (VP (VBZ has) (VP (VBN become) (NP (DT a) (JJ serious) (NN issue)) (, ,) (S (VP (VBG diminishing) (NP (NP (NN cancer) (NN treatment) (NNS outcomes)) (CC and) (NP (NP (NN quality)) (PP (IN of) (NP (NN life))))))))) (. .))
(S (NP (NP (NP (JJ Early) (NN detection)) (PP (IN of) (NP (NP (NN cancer) (NNS patients)) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NN cardiotoxicity))))))) (PP (IN before) (NP (JJ cardiotoxic) (NNS treatments)))) (CC and) (S (VP (VBG providing) (NP (JJ preventive) (NNS measures))))) (VP (VBP are) (NP (NP (JJ potential) (NNS solutions)) (SBAR (S (VP (TO to) (VP (VB improve) (NP (NP (NP (NN cancer) (NNS patients) (POS 's)) (NN quality)) (PP (IN of) (NP (NN life)))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ focuses) (PP (IN on) (S (VP (VBG predicting) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN heart) (NN failure))) (PP (IN in) (NP (NN cancer) (NNS patients))) (PP (IN after) (NP (NN cancer) (VBZ diagnoses)))) (S (VP (VBG using) (NP (JJ historical) (JJ electronic) (NN health) (NN record) (PRN (-LRB- -LRB-) (NNP EHR) (-RRB- -RRB-)) (NN data)))))))) (. .))
(S (NP (PRP We)) (VP (VBD examined) (NP (CD four) (NN machine) (VBG learning) (JJ algorithms)) (S (VP (VBG using) (NP (NP (CD 143,199) (NN cancer) (NNS patients)) (PP (IN from) (NP (NP (DT the) (NAC (NAC (NNP University) (PP (PP (IN of) (NP (NNP Florida))) (NNP Health))) (PRN (-LRB- -LRB-) (NP (NNP UF) (NNP Health)) (-RRB- -RRB-))) (NNP Integrated) (NNP Data) (NNP Repository)) (PRN (-LRB- -LRB-) (NP (NNP IDR)) (-RRB- -RRB-)))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD identified) (NP (NP (DT a) (JJ total) (NN number)) (PP (IN of) (NP (CD 1,958) (JJ qualified) (NNS cases))))) (CC and) (VP (VBD matched) (NP (PRP them)) (PP (TO to) (NP (CD 15,488) (NNS controls))) (PP (IN by) (NP (NP (NN gender)) (, ,) (NP (NN age)) (, ,) (NP (NN race)) (, ,) (CC and) (NP (JJ major) (NN cancer) (NN type)))))) (. .))
(S (NP (CD Two) (NN feature) (VBG encoding) (NNS strategies)) (VP (VBD were) (VP (VBN compared) (S (VP (TO to) (VP (VB encode) (NP (NNS variables)) (PP (IN as) (NP (NN machine) (NN learning) (NNS features)))))))) (. .))
(S (NP (DT The) (ADJP (ADJP (NN gradient) (NN boosting)) (PRN (-LRB- -LRB-) (NNP GB) (-RRB- -RRB-) (VBN based))) (NN model)) (VP (VBD achieved) (NP (NP (DT the) (JJS best) (NNP AUC) (NN score)) (PP (IN of) (NP (CD 0.9077)))) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 0.8520)))) (CC and) (NP (NP (DT a) (NN specificity)) (PP (IN of) (NP (CD 0.8138)))))) (-RRB- -RRB-)) (, ,) (S (VP (VBG outperforming) (NP (JJ other) (NN machine) (VBG learning) (NNS methods))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VP (VBD looked) (PP (IN into) (NP (NP (DT the) (NN subgroup)) (PP (IN of) (NP (NP (NN cancer) (NNS patients)) (PP (IN with) (NP (NP (NN exposure)) (PP (TO to) (NP (VB chemotherapy) (NNS drugs)))))))))) (CC and) (VP (VBD observed) (NP (NP (DT a) (JJR lower) (NN specificity) (NN score)) (PRN (-LRB- -LRB-) (NP (CD 0.7089)) (-RRB- -RRB-))))) (. .))
(S (NP (DT The) (JJ experimental) (NNS results)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NN machine) (NN learning) (NNS methods)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB capture) (NP (NP (JJ clinical) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NN heart) (NN failure))))))))))))))))))) (CC and) (SBAR (IN that) (S (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ feasible)) (S (VP (TO to) (VP (VB use) (NP (NN machine) (VBG learning) (NNS methods)) (S (VP (TO to) (VP (VB identify) (NP (NP (NN cancer) (NNS patients)) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NN cancer) (JJ therapy-related) (NN heart) (NN failure))))))))))))))))) (. .))
